HC Wainwright & Co.: Reiterates Buy rating on Evaxion Biotech (EVAX.US), adjusting target price from 14.00 USD to 14.00 USD.
HC Wainwright & Co.：重申Evaxion Biotech(EVAX.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至14.00美元。
HC Wainwright & Co.: Reiterates Buy rating on Evaxion Biotech (EVAX.US), adjusting target price from 14.00 USD to 14.00 USD.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.